IPO Series - Metro Healthcare Berhad - Paediatric and O&G Services 生育,产科和妇科服务
Metro Healthcare IPO 讲解:
1) YouTube
Figure 1: IPO timetable of METRO HEALTHCARE BERHAD
-Will be listed on the ACE Board
-Will be listed on the ACE Board
Info of IPO
Enlarged no. of shares upon listing: 978.905 million
IPO price: RM0.25
Market capitalization: RM244.72 million
Estimated funds to raise from Public Issue: RM39.16 million
PE ratio = 39.16x (based on FY2023)
Enlarged no. of shares upon listing: 978.905 million
IPO price: RM0.25
Market capitalization: RM244.72 million
Estimated funds to raise from Public Issue: RM39.16 million
PE ratio = 39.16x (based on FY2023)
Figure 2: Business model of METRO HEALTHCARE BERHAD
Source: METRO HEALTHCARE BERHAD IPO prospectus
Source: METRO HEALTHCARE BERHAD IPO prospectus
Figure 3: Utilisation of proceeds of METRO HEALTHCARE BERHAD
Source: METRO HEALTHCARE BERHAD IPO prospectus
Source: METRO HEALTHCARE BERHAD IPO prospectus
Dividend Policy
-The group targets a dividend payout ratio of at least 20% of the PAT
-The group targets a dividend payout ratio of at least 20% of the PAT
Figure 5: Major customers and suppliers of METRO HEALTHCARE in FPE2024
Source: METRO HEALTHCARE BERHAD IPO prospectus
Source: METRO HEALTHCARE BERHAD IPO prospectus
Figure 6: Profit & Loss statement of METRO HEALTHCARE BERHAD
Figure 7: Financial position of METRO HEALTHCARE BERHAD
Financial overview, industry market, and personal opinion
-The overview of the group’s financial position is poised to grow, with the total equity to total liabilities ratio of about 2, and the total assets have enlarged from RM50.238 million to RM57.886 million between FY2021 – FPE2024.
-Based on the marker research report, the industry size of Obstetrics and Gynaecology (O&G) has shown a CAGR of 14.2% from 2018 – 2023, signifying that the demand is anticipated to grow occasionally.
-Given the growing demand for O&G reasons, I agree with the researched data as lifestyle, disposable incomes, and food consumption habits have substantial differences from the last century.
-The overview of the group’s financial position is poised to grow, with the total equity to total liabilities ratio of about 2, and the total assets have enlarged from RM50.238 million to RM57.886 million between FY2021 – FPE2024.
-Based on the marker research report, the industry size of Obstetrics and Gynaecology (O&G) has shown a CAGR of 14.2% from 2018 – 2023, signifying that the demand is anticipated to grow occasionally.
-Given the growing demand for O&G reasons, I agree with the researched data as lifestyle, disposable incomes, and food consumption habits have substantial differences from the last century.
Disclaimer: The above content is not an investment advisory service and does not purport to tell or suggest which securities or stocks customers should buy or sell for themselves. It should not be assumed that the methods, techniques, or indicators presented above will be profitable or will not result in losses. You should not rely solely on information when making any investment. Rather, you should use the information only as a starting point for doing additional independent research to allow you to form your own opinion regarding investments.
The details of the IPO prospectus can be accessed through
METRO - INITIAL PUBLIC OFFERING IN CONJUNCTION WITH THE TRANSFER OF LISTING OF METRO HEALTHCARE BERHAD ("METRO" OR "COMPANY") FROM THE LEAP MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") TO THE ACE MARKET OF BURSA SECURITIES COMPRISING PUBLIC ISSUE OF 156,625,000 NEW ORDINARY SHARES...
METRO - INITIAL PUBLIC OFFERING IN CONJUNCTION WITH THE TRANSFER OF LISTING OF METRO HEALTHCARE BERHAD ("METRO" OR "COMPANY") FROM THE LEAP MARKET OF BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") TO THE ACE MARKET OF BURSA SECURITIES COMPRISING PUBLIC ISSUE OF 156,625,000 NEW ORDINARY SHARES...
By: Jshen Ng
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment